7 results on '"Fu, Xin-Yuan"'
Search Results
2. Factors That Influence Alternative Splice Site Selection in Vitro
- Author
-
MANLEY, JAMES L., primary, NOBLE, JONATHAN C.S., additional, FU, XIN-YUAN, additional, and GE, HUI, additional
- Published
- 1987
- Full Text
- View/download PDF
3. Nodal signaling from the visceral endoderm is required to maintain Nodal gene expression in the epiblast and drive DVE/AVE migration.
- Author
-
Kumar A, Lualdi M, Lyozin GT, Sharma P, Loncarek J, Fu XY, and Kuehn MR
- Subjects
- Animals, Endoderm cytology, Galactosides, Genes, Reporter genetics, In Situ Hybridization, Indoles, Mice, Mice, Inbred C57BL, Microscopy, Fluorescence, Mutagenesis, Nodal Protein genetics, Body Patterning physiology, Cell Movement physiology, Endoderm physiology, Gene Expression Regulation, Developmental physiology, Germ Layers metabolism, Nodal Protein metabolism, Signal Transduction physiology
- Abstract
In the early mouse embryo, a specialized population of extraembryonic visceral endoderm (VE) cells called the distal VE (DVE) arises at the tip of the egg cylinder stage embryo and then asymmetrically migrates to the prospective anterior, recruiting additional distal cells. Upon migration these cells, called the anterior VE (AVE), establish the anterior posterior (AP) axis by restricting gastrulation-inducing signals to the opposite pole. The Nodal-signaling pathway has been shown to have a critical role in the generation and migration of the DVE/AVE. The Nodal gene is expressed in both the VE and in the pluripotent epiblast, which gives rise to the germ layers. Previous findings have provided conflicting evidence as to the relative importance of Nodal signaling from the epiblast vs. VE for AP patterning. Here we show that conditional mutagenesis of the Nodal gene specifically within the VE leads to reduced Nodal expression levels in the epiblast and incomplete or failed DVE/AVE migration. These results support a required role for VE Nodal to maintain normal levels of expression in the epiblast, and suggest signaling from both VE and epiblast is important for DVE/AVE migration., (Published by Elsevier Inc.)
- Published
- 2015
- Full Text
- View/download PDF
4. Mouse hematopoietic cell-targeted STAT3 deletion: stem/progenitor cell defects, mitochondrial dysfunction, ROS overproduction, and a rapid aging-like phenotype.
- Author
-
Mantel C, Messina-Graham S, Moh A, Cooper S, Hangoc G, Fu XY, and Broxmeyer HE
- Subjects
- Acetylcysteine pharmacology, Anemia, Animals, Bone Marrow drug effects, Cell Differentiation drug effects, Cell Proliferation drug effects, Cells, Cultured, Erythroid Cells cytology, Erythroid Cells drug effects, Female, Free Radical Scavengers pharmacology, Humans, Male, Mice, Mice, Inbred C57BL, Mice, Knockout, Oxygen Consumption drug effects, Phenotype, Sequence Deletion, Aging pathology, Hematopoietic Stem Cells cytology, Hematopoietic Stem Cells metabolism, Mitochondria pathology, Reactive Oxygen Species metabolism, STAT3 Transcription Factor physiology
- Abstract
Nuclear transcription factor Stat3 is important for proper regulation of hematopoietic stem cell (HSC) and hematopoietic progenitor cell (HPC) proliferation, survival, and cytokine signaling responses. A new, noncanonical role for Stat3 in mitochondrial function has been discovered recently. However, there is little information on the role(s) of mitochondrial Stat3 in HSC/HPC function, especially potential effects of Stat3/mitochondrial dysregulation in human diseases. We investigated hematopoietic cell-targeted deletion of the STAT3 gene in HSCs/HPCs with a focus on mitochondrial function. We found that STAT3(-/-) mice, which have a very shortened lifespan, dysfunctional/dysregulated mitochondrial function and excessive reactive oxygen species production in HSCs/HPCs that coincides with pronounced defects in function. These animals have a blood phenotype with similarities to premature aging and to human diseases of myelodysplastic syndrome and myeloproliferative neoplasms such as erythroid dysplasia, anemia, excessive myeloproliferation, and lymphomyeloid ratio shifts. We show herein that the lifespan of STAT3(-/-) animals is lengthened by treatment with a reactive oxygen species scavenger, which lessened the severity of the blood phenotype. These data suggest a need for more detailed studies of role(s) of Stat3 in HSC/HPC mitochondrial function in human diseases and raise the idea that mitochondrial Stat3 could be used as a potential therapeutic target.
- Published
- 2012
- Full Text
- View/download PDF
5. Survivin mediates aberrant hematopoietic progenitor cell proliferation and acute leukemia in mice induced by internal tandem duplication of Flt3.
- Author
-
Fukuda S, Singh P, Moh A, Abe M, Conway EM, Boswell HS, Yamaguchi S, Fu XY, and Pelus LM
- Subjects
- Acute Disease, Animals, Caspase 3 metabolism, Cell Proliferation, Enzyme Activation, Gene Deletion, Humans, Inhibitor of Apoptosis Proteins, Leukemia genetics, Leukemia pathology, Mice, Mice, Transgenic, Microtubule-Associated Proteins antagonists & inhibitors, Microtubule-Associated Proteins genetics, Mutation genetics, Neoplasm Transplantation, Phosphatidylinositol 3-Kinases metabolism, Proto-Oncogene Proteins c-akt metabolism, Repressor Proteins, Survivin, Tumor Cells, Cultured, Up-Regulation, fms-Like Tyrosine Kinase 3 genetics, Hematopoietic Stem Cells cytology, Hematopoietic Stem Cells metabolism, Leukemia metabolism, Microtubule-Associated Proteins metabolism, fms-Like Tyrosine Kinase 3 metabolism
- Abstract
Internal tandem duplication mutations in the Flt3 tyrosine kinase gene (ITD-Flt3) and overexpression of Survivin are frequently found in patients with acute myeloid leukemia (AML). We investigated whether Survivin mediates the enhanced survival of primary hematopoietic progenitor cells (HPCs) resulting from ITD-Flt3 signaling. Ectopic ITD-Flt3 mutants increased Survivin expression in Ba/F3 cells downstream of PI3-kinase/Akt. Treatment of ITD-Flt3(+) human MV4-11 leukemia cells with the ITD-Flt3 inhibitor SU5416 reduced Survivin expression and inhibited cell proliferation. ITD-Flt3 dramatically increased the number of primary mouse marrow c-kit(+), Sca-1(+), Lin(Neg) cells and colony-forming unit granulocyte-macrophages (CFU-GMs) able to proliferate in the absence of growth factors, whereas Survivin deletion significantly reduced growth factor-independent proliferation and increased apoptosis, which was further accentuated by SU5416. Ectopic ITD-Flt3 reduced differentiation of Lin(Neg) marrow cells cultured with granulocyte-macrophage colony-stimulating factor (GM-CSF) plus stem cell factor, which was partially blocked by Survivin deletion. In addition, Survivin deletion decreased secondary colony formation induced by ITD-Flt3. Dominant-negative (dn)-Survivin delayed development of acute leukemia in mice that received a transplant of Ba/F3 cells expressing ITD-Flt3. These results suggest that Survivin regulates expansion of ITD-Flt3-transformed HPCs with self-renewal capability and development of ITD-Flt3(+) acute leukemia and that antagonizing Survivin may provide therapeutic benefit for patients with acute leukemia expressing ITD-Flt3.
- Published
- 2009
- Full Text
- View/download PDF
6. STAT3- and STAT5-dependent pathways competitively regulate the pan-differentiation of CD34pos cells into tumor-competent dendritic cells.
- Author
-
Cohen PA, Koski GK, Czerniecki BJ, Bunting KD, Fu XY, Wang Z, Zhang WJ, Carter CS, Awad M, Distel CA, Nagem H, Paustian CC, Johnson TD, Tisdale JF, and Shu S
- Subjects
- Animals, Bone Marrow Cells cytology, Bone Marrow Cells drug effects, Bone Marrow Cells physiology, Cell Differentiation drug effects, Cell Differentiation immunology, Cell Differentiation physiology, Dendritic Cells drug effects, Dendritic Cells metabolism, Female, Granulocyte-Macrophage Colony-Stimulating Factor pharmacology, Immunotherapy, Adoptive, Interleukin-6 pharmacology, Membrane Proteins pharmacology, Mice, Mice, Inbred BALB C, Mice, Inbred C3H, Mice, Inbred C57BL, Mice, Knockout, Neoplasms, Experimental immunology, Neoplasms, Experimental therapy, Recombinant Proteins, STAT3 Transcription Factor deficiency, STAT3 Transcription Factor genetics, Antigens, CD34 metabolism, Dendritic Cells cytology, Dendritic Cells immunology, STAT3 Transcription Factor metabolism, STAT5 Transcription Factor metabolism
- Abstract
The clinical outcomes of dendritic cell (DC)-based immunotherapy remain disappointing, with DCs often displaying a tenuous capacity to complete maturation and DC1 polarization in the tumor host. Surprisingly, we observed that the capacity for successful DC1 polarization, including robust IL12p70 production, could be regulated by STAT-dependent events even prior to DC differentiation. Exposure of CD34(pos) cells to single-agent granulocyte-macrophage colony-stimulating factor (GMCSF) induced multilineage, STAT5-dependent differentiation, including DCs that failed to mature in the absence of further exogenous signals. In contrast, Flt3L induced nearly global differentiation of CD34(pos) cells into spontaneously maturing DCs. IL-6 synergized with Flt3L to produce explosive, STAT3-dependent proliferation of phenotypically undifferentiated cells that nevertheless functioned as committed DC1 precursors. Such precursors not only resisted many tumor-associated immunosuppressants, but also responded to tumor contact or TGFbeta with facilitated DC maturation and IL12p70 production, and displayed a superior capacity to reverse tumor-induced T-cell tolerance. GMCSF preempted Flt3L or Flt3L plus IL-6 licensing by blocking STAT3 activation and promoting STAT5-dependent differentiation. Paradoxically, following overt DC differentiation, STAT5 enhanced whereas STAT3 inhibited DC1 polarization. Therefore, nonoverlapping, sequential activation of STAT3 and STAT5, achievable by sequenced exposure to Flt3L plus IL-6, then GMCSF, selects for multilog expansion, programming, and DC1 polarization of tumor-competent DCs from CD34(pos) cells.
- Published
- 2008
- Full Text
- View/download PDF
7. Osteoporosis with increased osteoclastogenesis in hematopoietic cell-specific STAT3-deficient mice.
- Author
-
Zhang Z, Welte T, Troiano N, Maher SE, Fu XY, and Bothwell AL
- Subjects
- Animals, Bone Resorption etiology, Carrier Proteins metabolism, Cell Differentiation, Cell Proliferation, Cells, Cultured, Hematopoietic Stem Cells, Membrane Glycoproteins metabolism, Mice, Osteoporosis complications, Proto-Oncogene Proteins c-fos metabolism, RANK Ligand, Receptor Activator of Nuclear Factor-kappa B, STAT3 Transcription Factor, Bone Remodeling, Bone Resorption metabolism, Bone Resorption pathology, DNA-Binding Proteins deficiency, Osteoclasts pathology, Osteoporosis metabolism, Osteoporosis pathology, Trans-Activators deficiency
- Abstract
Hematopoietic cell-specific disruption of the STAT3 gene induces hyperproliferation of cells of the myeloid lineage. Osteoclasts (OC), the bone-resorbing cells, are generated from the same precursors as monocyte/macrophages. STAT3 mutant mice exhibit decreased bone density, bone volume, and increased numbers of TRAP-positive OC. In vitro generation of OC showed significantly greater numbers of OC in mutant mice. The increased numbers of Mac1+ cells and c-kit+ cells were detected by FACS analysis, suggesting an increased number of OC precursors. Treatment of splenocytes with CSF-1 and RANKL significantly increased the Mac-1+RANK+ cells, with much higher levels observed in cells from mutant mice compared with littermate controls. Besides enhanced number of Mac1+ OC precursors, we also identified an OC-generating Mac1- c-kit+ population in mutant mice which was absent in littermate controls. The Mac1- c-kit- cells did not generate OC. Finally, we determined that protein expression and mRNA level of c-fos, a transcription factor which is essential for OC differentiation, were enhanced in OC precursors of mutant mice, which may contribute to the osteopenic phenotype.
- Published
- 2005
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.